VIA ELECTRONIC MAIL May 1, 2024 Antony C. Mattessich Newton, MA 02465 Dear Antony:Ocular Therapeutix, Inc • August 7th, 2024 • Pharmaceutical preparations • Massachusetts
As we discussed, your employment with Ocular Therapeutics, Inc. (the “Company”) will end effective May 2, 2024 (the “Separation Date”). In connection with the termination of your employment, you will be eligible to receive the severance benefits described in paragraph 1 below, if you sign and return this letter agreement to me on or before May 31, 2024, but no earlier than the Separation Date, and do not revoke your agreement as described below. By signing and returning this letter agreement and not revoking your agreement, you will be agreeing to the terms and conditions set forth in the numbered paragraphs below, including the release of claims set forth in paragraph 2. Therefore, you are advised to consult with an attorney before signing this letter agreement and you have been given at least twenty-one (21) days to do so. If you sign this letter agreement, you may change your mind and revoke your agreement during the seven (7) business day period after you have signed it (the “Revoc
Ocular Therapeutix, Inc.Ocular Therapeutix, Inc • August 7th, 2024 • Pharmaceutical preparations • Massachusetts
This letter confirms our agreement that the second sentence of the Employment Agreement shall be deleted and replaced by the following:
EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2024 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of April 15, 2024, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Nadia Waheed (“Executive”). This Agreement supersedes all prior agreements or exchanges between the parties and is intended to set forth the terms of Executive’s employment as of May 20, 2024 (the “Effective Date”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
VIA ELECTRONIC MAIL May 14, 2024 (as most recently revised on May 29, 2024) Dr. Rabia Gurses Ozden Edgewater, NJ 07020 Dear Rabia:Ocular Therapeutix, Inc • August 7th, 2024 • Pharmaceutical preparations • Massachusetts
This letter agreement confirms our agreement with respect to your planned separation from employment with Ocular Therapeutix, Inc. (the “Company”). As we discussed, provided you sign and return this letter agreement to me no earlier than your Separation Date but by June 5, 2024 and do not revoke your acceptance as described below, the Company will provide you with the severance benefits described in paragraph 2 below (the “Severance Benefits”). By timely signing, returning and not revoking your acceptance of this letter agreement, you will be entering into binding agreements with the Company and will be agreeing to the terms and conditions set forth herein and therein. Therefore, you are advised to consult with an attorney before signing this letter agreement and you have been given at least twenty-one (21) days to do so. If you sign this letter agreement, you may change your mind and revoke your acceptance during the seven (7) business day period after you have signed it (the “Revocat
